These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 17219688)

  • 1. Complications & side effects. Do statins affect CD4+ cell counts?
    TreatmentUpdate; 2004; 16(7):8-9. PubMed ID: 17219688
    [No Abstract]   [Full Text] [Related]  

  • 2. Complications & side effects. Can statins be used as anti-HIV drugs?
    TreatmentUpdate; 2004; 16(7):9. PubMed ID: 17219689
    [No Abstract]   [Full Text] [Related]  

  • 3. Statins may not affect CD4 response.
    Gadd C
    IAPAC Mon; 2006 Feb; 12(2):33. PubMed ID: 17249133
    [No Abstract]   [Full Text] [Related]  

  • 4. Long-term statin use does not act on the temporal trend of CD4 cell count in patients on virologically effective HAART.
    Manfredi R; Calza L; Chiodo F
    AIDS; 2006 Feb; 20(3):455-7. PubMed ID: 16439881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolonged statin administration does not act on the cell-mediated immunity of HIV-infected dyslipidemic patients treated with a steady and effective highly active antiretroviral therapy. A two-year prospective study of statin versus fibrate administration.
    Manfredi R; Calza L; Chiodo F
    J Biol Regul Homeost Agents; 2006; 20(1-2):1-9. PubMed ID: 18088548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the anti-HIV activity of statins.
    Moncunill G; Negredo E; Bosch L; Vilarrasa J; Witvrouw M; Llano A; Clotet B; Esté JA
    AIDS; 2005 Oct; 19(15):1697-700. PubMed ID: 16184043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Side effects and complications. Can statins help reverse body-shape changes in men?
    TreatmentUpdate; 2005 Dec; 17(7):11-2. PubMed ID: 17228404
    [No Abstract]   [Full Text] [Related]  

  • 8. CD4+ T cell count recovery in HIV type 1-infected patients is independent of class of antiretroviral therapy.
    Khanna N; Opravil M; Furrer H; Cavassini M; Vernazza P; Bernasconi E; Weber R; Hirschel B; Battegay M; Kaufmann GR;
    Clin Infect Dis; 2008 Oct; 47(8):1093-101. PubMed ID: 18783328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ezetimibe and atorvastatin both immunoregulate CD4+ T cells from cardiac transplant recipients invitro.
    Shaw SM; Najam O; Khan U; Yonan N; Williams SG; Fildes JE
    Transpl Immunol; 2009 Jul; 21(3):179-82. PubMed ID: 19332119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complications and side effects. Concerns about statins.
    TreatmentUpdate; 2005; 17(4):5-6. PubMed ID: 17228472
    [No Abstract]   [Full Text] [Related]  

  • 11. Correlation of mucocutaneous manifestations of HIV/AIDS infection with CD4 counts and disease progression.
    Nnoruka EN; Chukwuka JC; Anisuiba B
    Int J Dermatol; 2007 Oct; 46 Suppl 2():14-8. PubMed ID: 17958624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurological complications in patients with HIV/AIDS.
    Bolokadze N; Gabunia P; Ezugbaia M; Gatserelia L; Khechiashvili G
    Georgian Med News; 2008 Dec; (165):34-8. PubMed ID: 19124914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study on CD4 cell responses in HIV infected subjects in Nepal.
    Tiwari BR; Ghimire P; Malla S
    Nepal Med Coll J; 2008 Mar; 10(1):45-7. PubMed ID: 18700632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Susceptibility to opportunistic infections in HIV-infected patients with increased CD4 T-cell counts on antiretroviral therapy may be predicted by markers of dysfunctional effector memory CD4 T cells and B cells.
    French M; Keane N; McKinnon E; Phung S; Price P
    HIV Med; 2007 Apr; 8(3):148-55. PubMed ID: 17461858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating memory B-cell subpopulations are affected differently by HIV infection and antiretroviral therapy.
    D'Orsogna LJ; Krueger RG; McKinnon EJ; French MA
    AIDS; 2007 Aug; 21(13):1747-52. PubMed ID: 17690573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low CD4 T-cell counts despite low levels of circulating HIV: insights from the comparison of HIV-1 infected patients with a discordant response to antiretroviral therapy to patients with untreated advanced HIV-2 disease.
    Albuquerque AS; Foxall RB; Cortesão CS; Soares RS; Doroana M; Ribeiro A; Lucas M; Antunes F; Victorino RM; Sousa AE
    Clin Immunol; 2007 Oct; 125(1):67-75. PubMed ID: 17692571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreasing CD4+ T-cell count during suppressed or low-level viraemia in patients with HIV infection.
    Anderson AM; Kosinski AS; Bartlett JA
    Antivir Ther; 2007; 12(7):1041-8. PubMed ID: 18018762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Setting a minimum threshold CD4 count for initiation of highly active antiretroviral therapy in HIV-infected patients.
    Ho C; Lee S; Wong Kh; Cheng L; Lam M
    HIV Med; 2007 Apr; 8(3):181-5. PubMed ID: 17461862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complications & side effects. HAART and bones-mixed messages.
    TreatmentUpdate; 2007; 19(4):3-5. PubMed ID: 17969257
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment initiation with zidovudine-containing potent antiretroviral therapy impairs CD4 cell count recovery but not clinical efficacy.
    Huttner AC; Kaufmann GR; Battegay M; Weber R; Opravil M
    AIDS; 2007 May; 21(8):939-46. PubMed ID: 17457087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.